Results 61 to 70 of about 6,958,062 (166)
Mapping the immune environment in clear cell renal carcinoma by single-cell genomics
Clear cell renal cell carcinoma (ccRCC) is one of the most immunologically distinct tumor types due to high response rate to immunotherapies, despite low tumor mutational burden.
N. Borcherding +9 more
semanticscholar +1 more source
Dysembryoplastic Neuroepithelial Tumor: A Benign but Complex Tumor of the Cerebral Cortex [PDF]
Dysembryoplastic neuroepithelial tumor (DNET) is a distinct type of low-grade glioneuronal tumor. Clinically, DNET is highly associated with intractable epilepsy in young children and adolescents.
김세훈
core +1 more source
The current role of renal biopsy in the management of localized renal tumors
Introduction : In the current era of nephron-sparing surgery (NSS) for localized tumors, pretreatment tissue biopsy is being revisited and re-evaluated.
Gagan Gautam, Kevin C Zorn
doaj +1 more source
Objectives: To develop and validate a machine learning-based CT radiomics classification model for distinguishing benign renal tumors from malignant renal tumors.
Seokhwan Bang +6 more
doaj +1 more source
Progressive immune dysfunction with advancing disease stage in renal cell carcinoma
SUMMARY The tumor immune microenvironment plays a critical role in cancer progression and response to immunotherapy in clear cell renal cell carcinoma (ccRCC), yet the composition and phenotypic states of immune cells in this tumor are incompletely ...
D. Braun +34 more
semanticscholar +1 more source
ObjectiveTo discuss the differences in the effectiveness and security for T1 renal tumors by radiofrequency ablation (RFA) and cryoablation (CA).MethodsWe systematically searched the Cochrane Library, PubMed, Embase, CNKI databases, and Science databases,
Hongjin Shi +7 more
doaj +1 more source
Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal
Summary The evolutionary features of clear-cell renal cell carcinoma (ccRCC) have not been systematically studied to date. We analyzed 1,206 primary tumor regions from 101 patients recruited into the multi-center prospective study, TRACERx Renal.
S. Turajlić +69 more
semanticscholar +1 more source
Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment
Cancer causes the second-highest rate of death world-wide. A major shortcoming inherent in most of anticancer drugs is their lack of tumor selectivity.
M. Subhan +4 more
semanticscholar +1 more source
Cell surface engineering of renal cell carcinoma with glycosylphosphatidylinositol-anchored TIMP-1 blocks TGF-beta 1 activation and reduces regulatory ID gene expression [PDF]
Tissue inhibitor of metalloproteinase 1 (TIMP-1) controls matrix metalloproteinase activity through 1:1 stoichiometric binding. Human TIMP-1 fused to a glycosylphosphatidylinositol (GPI) anchor (TIMP-1-GPI) shifts the activity of TIMP-1 from the ...
Notohamiprodjo, Susan +5 more
core +1 more source
Recent advances in proteomic profiling technologies, such as surface enhanced laser desorption ionization mass spectrometry, have allowed preliminary profiling and identification of tumor markers in biological fluids in several cancer types and ...
Rogers, M. A. +6 more
core +1 more source

